Regulations for medical devices are transferred to the Norwegian Medicines Agency

17

Jan 2018

The medical equipment area is under the responsibility of Medicines Agency in Denmark, Sweden and in most other EU countries. The technological development in this area is moving fast. A new regulatory framework for medical devices has been adopted by the EU Parliament on April 5, 2017. Introduction of new regulations has required transfer of the management of medical devices from the Norwegian Directorate of Health to the Norwegian Medicines Agency.

The transfer does not involve any change of responsibility or roles related to the prescription / Norwegian Health Economics Administration (HELFO) / reimbursement of medical devices. It also does not cover electromedical equipment under the responsibility of the Directorate for Social Security and Emergency Planning (Direktoratet for samfunnssikkerhet og beredskap).

See full details in the Norwegian here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

23

Feb 2022

On January 24, 2022, the Norwegian Directorate of e-Health released an updated version of the National Laboratory code (NLK) system and associated tariffs for state and private laboratories to be implemented no later than March 01, 2022. NLK system has been used for activity-based reimbursement by the Norwegian Health Economics Administration (Helfo) in outpatient settings since 2018. Thirty new codes were added medical biochemistry, medical microbiology, immunology and transfusiology, and clinical pharmacology areas.

Read more

02

Feb 2022

The "New Method" is currently developing criteria for which methods other than drugs shall be prioritized for assessment within the framework at the national or local levels. On January 17, 2022, the project status was presented at the Ordering Forum for "New Method." It was reported that the project would require more resources and time than initially thought.

Read more

03

Dec 2021

On November 23, 2021, the Norwegian Directorate of e-Health released an updated version of the National Laboratory code (NLK) system and associated tariffs for state and private laboratories to be implemented no later than January 01, 2021. NLK system has been used for activity-based reimbursement by the Norwegian Health Economics Administration (Helfo) in outpatient settings since 2018. Thirty new codes were added in medical biochemistry, immunology and transfusiology, and clinical pharmacology areas.

Read more

29

Oct 2021

On September 27, 2021, the Decision Forum for "New Methods" decided not to introduce bronchial thermoplasty as a routine treatment of patients with severe asthma. The method should only be used within clinical trials.

Read more

26

Oct 2021

On September 23, 2021, the Norwegian Directorate of e-Health released an updated version of the National Laboratory code (NLK) system and associated tariffs for state and private laboratories to be implemented no later than November 01, 2021. NLK system has been used for activity-based reimbursement by the Norwegian Health Economics Administration (Helfo) in outpatient settings since 2018. Thirty-nine new codes were added in medical biochemistry, clinical pharmacology, and medical microbiology areas.

Read more